Neuropace Inc. (NPCE)
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
NPCE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $437.98M
- EPS (TTM)
- -$0.57
- Dividend yield
- None
- 52-week range
- 9.22 – 19.60
- Day range
- 12.58 – 13.06
- Volume / Avg
- 127.17K / 170.54K
- Beta
- —
- Shares outstanding
- 34.32M
- Next earnings
- Nov 3, 2026
52-week range
NPCE stock today
Neuropace (NPCE) closed at $12.76 on Oct 7, up 0.71% (+$0.09), versus the S&P 500's 0.22% decline. At this level, NPCE sits in the middle of its 52-week range of $9.22 to $19.60: 34.9% below the high, set on May 8, 2026 and 38.4% above the low. NPCE is down 17.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 19.8%.
Neuropace has posted a net loss over the last twelve months (EPS of -$0.57), so its P/E ratio is not meaningful. Neuropace's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Neuropace
Company profile- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.14
NPCE news
All NPCE newsNeuropace peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CERSCerus Corporation | 2.29 | -2.14% | $461.49M | vs NPCE |
| RCELAvita Medical Inc. | 13.05 | +0.46% | $403.60M | vs NPCE |
| SGHTSight Sciences Inc. | 8.47 | -1.05% | $466.60M | vs NPCE |
| BWAYBrainsWay Ltd. ADR | 11.62 | -2.27% | $467.74M | vs NPCE |
| CARLCarlsmed Inc. | 14.38 | -1.78% | $392.61M | vs NPCE |
| SIShoulder Innovations Inc. | 18.71 | -2.25% | $389.52M | vs NPCE |
| SENSSenseonics Holdings Inc. | 9.16 | -8.03% | $484.33M | vs NPCE |
| OFIXOrthofix Medical Inc. | 9.20 | -2.23% | $371.88M | vs NPCE |
Indexes, lists and sector
Neuropace stock FAQ
What is Neuropace's stock price today?
NPCE last traded at $12.76 as of Oct 7, 4:00 PM EDT, up 0.71% on the day. Prices are delayed at least 15 minutes.
When is Neuropace's next earnings date?
Neuropace is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.14.
What is the NPCE 52-week high?
The 52-week high for NPCE is $19.60 and the 52-week low is $9.22. The stock is currently 34.9% below its high.